Placebo of Hepalatide

DRUG2 trials

Sponsors

Shanghai HEP Pharmaceutical Co., Ltd.

Conditions

Chronic Hepatitis BHepatitis D, Chronic

Phase 2

A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients

CompletedNCT05244057

Shanghai HEP Pharmaceutical Co., Ltd.Chronic Hepatitis B

Start: 2022-08-23End: 2024-06-24Updated: 2024-07-15

Phase 3

Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D

Not yet recruitingNCT07309380

Shanghai HEP Pharmaceutical Co., Ltd.Hepatitis D, Chronic

Start: 2026-04-30End: 2027-08-31Target: 150Updated: 2025-12-30